Loading clinical trials...

Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms | Clinical Trials | Clareo Health

COMPLETEDNA

Analysis of Thrombo-embolic Complications After Endovascular Treatment of Unruptured Intracranial Aneurysms

NCT02862756•CHU de Reims

View on ClinicalTrials.gov

Summary

Endovascular treatment of ruptured and unruptured intracranial aneurysms presents complications, mainly the thrombo-embolic complication. No specific studies have been conducted to study factors associated with the occurrence of thromboembolic complications (symptomatic or not) post endovascular treatment of intracranial aneurysms.

Detailed Description

In this multicenter, prospective study, patients with treatment of unruptured intracranial aneurysms will be recruited. The thromboembolic complications will be research using diffusion-weighted MRI.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•patient having a programmed endovascular treatment for unruptured intracranial aneurysm
•patient older than 18 years
•patient consenting to participate to the study
•patient enrolled in the national healthcare insurance program

Exclusion Criteria

•patients with contraindications for MRI
•patients whose clinical condition does not allow sufficient cooperation to the realization of MRI
•patients with arteriovenous malformation intracranial

Locations (1)

Chu de Reims

Reims, France

Key Dates

Start Date

November 14, 2016

Primary Completion Date

March 12, 2020

Completion Date

March 9, 2021

Last Updated

May 13, 2021

Enrollment

250

ACTUAL participants

Conditions

Unruptured Intracranial Aneurysms

Interventions

diffusion-weighted MRI and clinical examination

OTHER

Acetylsalicylic Acid Plus Intensive Blood Pressure Treatment in Patients With Unruptured Intracranial Aneurysms

NCT03063541

Unruptured Intracranial Aneurysms

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 13, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions